
ãã€ã¿ãŒã¯RFKãžã¥ãã¢ãæ¹å€ããèšäºãæ²èŒããããéã«åœŒãã¯ã¯ãã³æ¿çæ¹é©ã«ã©ãã»ã©å°œåããŠããããæããã«ããŸãã
å èšäºã¯ãã¡ããã/Click here to read the original article.
ãã€ã¿ãŒéä¿¡ãç«ææ¥ã«å ±ãããšããã«ãããšããã€ã¿ãŒã¯ç«ææ¥ã«ããã€ãŠã¯èããããªãã£ãäžé£ã®å ¬è¡è¡çææ¡ããã©ã³ãæ¿æš©ã®æé«ã¬ãã«ã«æã¡èŸŒãã ããšå ±ãããåãã¥ãŒã¹ã¡ãã£ã¢ã¯ãã±ããã£æ°ã®ã¯ã¯ãã³æ¿çãå ¬è¡è¡çãå±éºã«ããããŠãããšç€ºåããŸããããåæã«HHSã®è²¬ä»»è ã«å°±ä»»ããŠä»¥æ¥ã®ã¯ã¯ãã³é¢é£ã®åãçµã¿ãå æ¬çã«èª¬æããŠããŸãã
ãã€ã¿ãŒéä¿¡ãç«ææ¥ã«å ±ãããšããã«ãããšããã€ã¿ãŒéä¿¡ã«ãããšãç±³åœä¿å¥é·å®ãããŒãã»Fã»ã±ããã£ã»ãžã¥ãã¢ã¯ããã€ãŠã¯èããããªãã£ãå ¬è¡è¡çã«é¢ããäžé£ã®ææ¡ããã©ã³ãæ¿æš©ã®æé«ã¬ãã«ã«æã¡èŸŒãã ããšè¿°ã¹ãŠããŸãã
ãã€ã¿ãŒã®å ±åã¯ãã±ããã£ã®ã¯ã¯ãã³æ¿çãå ¬è¡è¡çãå±éºã«ããããŠãããšç€ºåããŠããŸãããåæã«åœŒãç±³åœä¿å¥çŠç¥ç(HHS)ã®é·å®ã«å°±ä»»ããŠä»¥æ¥ã®ã¯ã¯ãã³é¢é£ã®åãçµã¿ãå æ¬çã«èª¬æããŠããŸãã
ãã€ã¿ãŒã«ãããšãã±ããã£ã¯ãè€æ°ã®ãã¯ã€ãããŠã¹äžçŽè£äœå®ã®èŠè«ã«å¿ããŠãã¯ã¯ãã³ã«ã€ããŠå ¬ã«è©±ãããšãé¿ããããšã«åæããããšãããŠããŸãããŸãããæ¿åºã®ããŸããŸãªæ¹é¢ããã®æµæã«çŽé¢ããã¯ã¯ãã³æ¿çã®ããã€ãã®èŠçŽ ã宿œã§ããŠããªãããšãè¿°ã¹ãŠããŸãã
ãããããè£ã§ãã±ããã£ã¯ãå€ãã®ã¯ã¯ãã³ãé©åã«è©ŠéšãããŠããããããŸããŸãªå±éºãªå¯äœçšãåŒãèµ·ããå¯èœæ§ããããšããèªèº«ã®çè«ã®èšŒæ ãæ¢ãç¶ããŠããããšè¿°ã¹ãŠããŸããããã¯ãã±ããã£ãåã©ãã®ã¯ã¯ãã³å®å šæ§ãç ç©¶ããããã«ãéäžçãªãåãçµã¿ãäž»å°ããŠãããšãããã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºã®5æã®å ±éãè£ä»ããŠããŸãã
ãã€ã¿ãŒã¯é£éŠæ¿åºã®çŸè·ããã³å å ¬åå¡16人ãžã®ã€ã³ã¿ãã¥ãŒãåŒçšããã±ããã£æ°ãã¯ã¯ãã³ãšèªéçã®é¢é£æ§ãç ç©¶ããããšããåªåãæšå¥šãããåã©ãã®äºé²æ¥çš®ã¹ã±ãžã¥ãŒã«ã®æ¹èšããããŠåœå®¶ã¯ã¯ãã³å·å®³è£åããã°ã©ã (VICP)ã®å·æ°ã«åããåãçµã¿ã匷調ããŸããã
ãã€ã¿ãŒã«ãããšãã±ããã£ã¯ãŸããããã«ãã»ãã©ã³ã倧統é ãšå®æçã«äŒããã¯ã¯ãã³é¢é£æ¿çãã¯ã¯ãã³ãšèªéçã®é¢é£ã«ã€ããŠè©±ãåã£ãŠããŸãã
Substackã®æçš¿ã§ãå ç§å»ã§Door to Freedomã®åµèšè ã§ããã¡ãªã«ã»ãã¹å»åž«ã¯ããã€ã¿ãŒã®ã±ããã£ã«é¢ããå ±åã¯ãæ»æèšäºããšããŠæå³ãããŠããããå®éã«ã¯ãåœŒã®æ¯æè ãã¡ãç¹ã«æ¿æš©ã®ãMake America Healthy Again(MAHA)ãã®æ¯æè ã«å¥œãããããšã«ãªãã ããããšæžããŠããŸãã
ãRFKã¯äžéšã®äººã䞻匵ããããã«å£²ãæž¡ããããã§ã¯ãªãããšãã¹ã¯æžããŠããŸãã圌女ã¯å¥ã«The Defenderã«å¯Ÿãããã€ã¿ãŒã®å ±éã¯ãã±ããã£ã劚ããããŠããå€ãã®åªåã«ã€ããŠè«ããåããŠã®èšäºã ããšèªã£ãã
ã圌ã«ã¯ãã¯ã€ãããŠã¹ã¹ã¿ãããä¿å¥çŠç¥çã¹ã¿ããå ã«å€ãã®æµãããããšãããããŸããããã®èšäºã¯åœŒãé¥ã£ã倧éã®äžãå£éèŠããŠãããŸãããšãã¹ã¯èªããŸããã
圌女ã¯ããã ãœã³ã»ãã€ã¿ãŒè²¡å£ã®äŒé·ã§ãããžã§ãŒã ãºã»Cã»ã¹ãã¹æ°ããã¡ã€ã¶ãŒã®åç· åœ¹äŒã¡ã³ããŒã§ããããšã«è§ŠããŸããã
ã¯ã¯ãã³é¢é£ã®åé¡ã«ã€ããŠã±ããã£ã«å©èšããåŒè·å£«ã¢ãŒãã³ã»ã·ãªãåæããŸããã圌ã¯The Defenderã«å¯Ÿããã±ããã£ã®VICPæ¹é©ã®åãçµã¿ã«é¢ããå ±éã«ãæºè¶³ããŠããããšèªããŸããã
ãã€ã¿ãŒã¯ãã±ããã£ããæ°å幎ã¶ãã®ç±³åœã¯ã¯ãã³æ¿çã®æå€§çŽã®å€æŽãæšé²ããŠããããšèªãããçŸç¶ãè§£äœããããã«ãããŸã§ç¥ãããŠãã以äžã®ããšã詊ã¿ãŠããããšè¿°ã¹ãŠããŸãã
ãã€ã¿ãŒã¯ãŸããåé信瀟ãChildren's Health Defenseãã«ãã蚎èšã®è¢«åã§ãããšå ±ããŸãããTrusted News Initiativeã¯ãã€ã¿ãŒãã¯ã·ã³ãã³ã»ãã¹ããAPéä¿¡ãBBCãªã©ãçµæããããŒãããŒã·ããã§ãã
蚎èšã¯ãå ±éæ©é¢ãããã¯ãã©ãããã©ãŒã ãšå ±è¬ããŠä»£æ¿èŠè§£ãæ€é²ããå°èŠæš¡ãªç¬ç«ç³»ãã¥ãŒã¹ãµã€ããç«¶äºäžäžå©ã«ããããšã§ç¬å çŠæ¢æ³ã«éåãããšäž»åŒµããŠããŸãã
HHSã¯ããã€ã¿ãŒã®å ±éã«é¢ãããã£ãã§ã³ããŒã®ã³ã¡ã³ãèŠè«ã«å¯Ÿããå ±éæãŸã§ã«åçããŸããã§ããã
ãã€ã¿ãŒã¯RFKãžã¥ãã¢ã®ã¯ã¯ãã³é¢é£ã®ããã€ãã®ææãåãäžããŠããŸã
ãã€ã¿ãŒã«ãããšãã±ããã£ã®ã¯ã¯ãã³æ¿çã®äž»ãªãã€ã©ã€ãã«ã¯ãmRNAã¯ã¯ãã³éçºã®çž®å°ãåœéã¯ã¯ãã³åçãžã®è³éæäŸã®æ€åãCOVIDã¯ã¯ãã³ãžã®ã¢ã¯ã»ã¹åŒ·åããå«ãŸããŸãã
2025幎8æãã±ããã£ã¯mRNAã¯ã¯ãã³éçºã«å²ãåœãŠããã5åãã«ã®é£éŠå¥çŽãšå©æéããã£ã³ã»ã«ããŸããããã€ã¿ãŒã¯å æãç±³åœé£åå»è¬åå±(FDA)ã®é¡§åãã¢ãã«ãã®mRNAã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®æ¿èªãå§åããããšãèšäºã®äžã§å«ããŠããŸããã
2025幎6æãã±ããã£ã¯é£éŠæ¿åºãGavi(ã¯ã¯ãã³ã»ã¢ã©ã€ã¢ã³ã¹)ãžã®è³éæäŸã忢ãããšçºè¡šããŸããããã®ã¯ã¯ãã³ã¢ã©ã€ã¢ã³ã¹ã¯ãäžççã«åã©ãã®ã¯ã¯ãã³æ¥çš®ãä¿é²ãã宿°ããŒãããŒã·ããã§ãã
ã²ã€ã財å£ã¯ã¬ãã«ãšã£ãŠæå€§ã®æ°éå¯ä»è ã§ãã1999幎ã®Gaviã®ç«ã¡äžãã«ãè³éãæäŸãããã®è²¡å£ã¯ãGaviã®åç· åœ¹äŒã«åžžä»»ã®åžãä¿æããŠããŸããã²ã€ã財å£ãšã¬ãã¯äžçä¿å¥æ©é¢(WHO)ãžã®æå€§çŽã®ãããŒã§ããããŸãã
ãã©ã³ãæ¿æš©ã¯ä»å¹Žåãã«æ£åŒã«ç±³åœãWHOããè±éããããã©ã³ãæ°ã2025幎ã«å°±ä»»ããŠéããªãçŽæããããšãæãããŸããã
æšå¹Žãç±³åœã¯äºé²æ¥çš®ã«é¢ããè«®åå§å¡äŒ(ACIP)ã®æç¥šãåãã6ãæãã64æ³ãŸã§ã®äººã ã®COVID-19ã¯ã¯ãã³æ¥çš®ã«ã€ããŠãå人åäœã®æææ±ºå®ããæšå¥šããæ°ããªCOVID-19ã¯ã¯ãã³ã¬ã€ãã³ã¹ãæ¡çšããŸãããACIPã¯çŸç 察çã»ã³ã¿ãŒ(CDC)ã«ã¯ã¯ãã³æ¿çã«ã€ããŠå©èšããŠããŸãã
2025幎5æãCDCã¯å¥åº·ãªåã©ããšå¥åº·ãªåŠå©Šã«å¯ŸããCOVID-19ã¯ã¯ãã³æ¥çš®ã®æšå¥šã忢ããŸããããã®å€æŽãšãã®åŸã®å€æŽã«ãããã¢ã¡ãªã«å°å ç§åŠäŒãä»ã®å»çå£äœãã±ããã£ãšä¿å¥çŠç¥çã蚎ããŸããã
3æã«ã¯ãé£éŠè£å€æãCOVID-19ã¯ã¯ãã³æ¿çã®å€æŽã忢ããåæ©é¢ãæ¿èªããä»ã®ã¯ã¯ãã³æ¿çã®å€æŽãåæ§ã§ããã5æãHHSã¯é£éŠè£å€æã®å€æ±ºã«å¯ŸããŠæ§èšŽããŸãããæ§èšŽã¯çŸåšä¿äºäžã§ãã
HHSã¯RFKãžã¥ãã¢ãå ç«¥ã¯ã¯ãã³ã¹ã±ãžã¥ãŒã«ã®å»æ¢ãæ±ãããšãã䞻匵ãåŠå®ããŠããŸã
ã±ããã£æ°ã«ããCOVID-19ã¯ã¯ãã³æšå¥šã®å€æŽããæšå¥šãããåã©ãã®äºé²æ¥çš®ã¹ã±ãžã¥ãŒã«ããããŠæ¿ç宿œã§çŽé¢ããé害ã¯ããã€ã¿ãŒã®å ±åæžã®äžå¿çãªçŠç¹ã§ããã
ããã«ã¯ãã±ããã£ãå ç«¥äºé²æ¥çš®ã¹ã±ãžã¥ãŒã«å šäœã廿¢ãã代ããã«å»åž«ãšèŠªãä¿è·è ã®éã§ãå ±æãããèšåºæææ±ºå®ããæšå¥šããããšãããšããããããŸã§å ±éãããŠããªãã£ã䞻匵ãå«ãŸããŠããŸããã
ãã€ã¿ãŒã¯ãå FDAé·å®ããŒãã£ã»ãã«ãªãŒ(5æã«èŸä»»)ããåæã«è§£ä»»ããããŸã§FDAã®å»è¬åè©äŸ¡ç ç©¶ã»ã³ã¿ãŒã®ä»£çæé·ãåããŠãããã¬ã€ã·ãŒã»ãã¹ã»ããŒã°å»åŠå士ããã±ããã£ã®èšç»ã«ãèŠæãããåã©ãã®ã¹ã±ãžã¥ãŒã«ã®å®å šãªå»æ¢ããåé¿ãããããšãããšå¿åã®é¢ä¿è ãåŒçšããã
HHSã®åºå ±æ åœã³ãŒãããŒã»ã¹ãã³ãµãŒã¯ãããã®äž»åŒµã®æ£ç¢ºæ§ã«ç°è°ãå±ãããšãã€ã¿ãŒéä¿¡ã¯å ±ããŠããŸããããŒã°ã¯ãã£ãã§ã³ããŒçŽã®ã³ã¡ã³ãèŠè«ã«å¿ããªãã£ãã
ãã€ã¿ãŒã«ãããšãã±ããã£éŠçžãå ç«¥äºé²æ¥çš®ã¹ã±ãžã¥ãŒã«ã®èŠçŽããæ€èšããéã圌ãšé¡§åãã¡ã¯ã¯ããã»ãããµã颚éª(MMR)ã¯ã¯ãã³ãšããªãªã¯ã¯ãã³ãã¹ã±ãžã¥ãŒã«ããå€ããã©ãããè°è«ããŸããã
ãããããã€ã¿ãŒéä¿¡ã«ãããšãã±ããã£ã¯æçµçã«ãæ¿æ²»çãªåçºã®å¯èœæ§ããããã¯ã€ãããŠã¹é¢ä¿è ããã®åçºãã«ãããããã®èããæ€åããã
RFKãžã¥ãã¢ã¯ã¯ã¯ãã³ãšèªéçã®é¢é£ã«é¢ããç ç©¶ããåŒãäžãããããšãç®æããŸãã
ãã€ã¿ãŒã¯ãŸããã±ããã£ãã¯ã¯ãã³ãšèªéçã®é¢é£æ§ãç ç©¶ããããšããåªåã«ã泚ç®ããŸããããã€ã¿ãŒã«ãããšãã±ããã£ã¯ãã®åé¡ããé«ãããããšããŸããã
2人ã®å¿åã®é¢ä¿è ã®è©±ãåŒçšãããã€ã¿ãŒã¯ä»å¹Žåãã«ã±ããã£ãåœç«è¡çç ç©¶æ(NIH)æé·ãžã§ã€ã»ãã¿ãã£ãªã€ã«å¯Ÿããã¯ã¯ãã³ãšèªéçã®é¢é£ã調æ»ããç ç©¶ã«50åãã«ãå²ãåœãŠãèšç»ãæç€ºãããšå ±ãããããã€ã¿ãŒã¯ãã®ä»®èª¬ããäžçäžã®ç§åŠè ã«ãã£ãŠåŠå®ãããããšäž»åŒµããŠããã
ãã€ã¿ãŒã«ããã°ãã±ããã£ã¯è°äŒã®æ¿èªãå¿ èŠã§ããããŸã2025幎9æã«éå§ãããNIHã®ã¯ã¯ãã³ãšèªéçã®é¢é£ã調æ»ãã5,000äžãã«ã®ç ç©¶ã€ãã·ã¢ãããšéãªã£ãŠããããããã®èšç»ãæ€åããŸããã
ãã®æãHHSã¯ã¯ã¯ãã³ãå«ãèªéçã®ããããåå ã調æ»ãããšçºè¡šããŸããã2025幎11æãCDCã¯èªéçã«é¢ãããŠã§ãããŒãžãæ¹èšããã¯ã¯ãã³ãèªéçãåŒãèµ·ãããªããšããå æ¬çãªäž»åŒµãè£ä»ãã蚌æ ã¯ãªããšè¿°ã¹ãŸããã
ãã€ã¿ãŒã¯çŸè¡ã®ã¯ã¯ãã³å·å®³è£åå¶åºŠã«åé¡ãããããšãèªããŠããŸã
ãã€ã¿ãŒã®å ±éã¯ãŸããã±ããã£ããæ¿åºå éšããVICPãå€ããããšãããåªåã匷調ããçŸè¡å¶åºŠã®äžã§ã¯ã¯ãã³è¢«å®³ã蚎ããè«æ±è ãåããããéãããæå®³è³ åããææããŸããã
ãã€ã¿ãŒã«ãããšãVICPã®ãããªæ¿åºéå¶ã®ã¯ã¯ãã³å·å®³è£åå¶åºŠã¯å¿ èŠã§ãããªããªããã¯ã¯ãã³ã¡ãŒã«ãŒã«çŽæ¥è²¬ä»»ãè² ãããããšã¯ãæ£è ãæå¶ãªã蚎èšãèµ·ãããå Žåãããã®äŒç€Ÿã廿¥ã«è¿œã蟌ãå¯èœæ§ãããããã§ãã
ããããå ±åæžã¯çŸè¡ã®ã·ã¹ãã ã«æ¬ é¥ãããã補è¬äŒç€Ÿã¯ãä»ã®å»è¬åã«å¯ŸããŠãã®ãããªä¿è·ããªãããšèªããŠããŸãã
æšå¹Žãã±ããã£ã¯çŸåšã®VICPããå·é ·ããšè¡šçŸããŸãããå é±ãã±ããã£æ°ã¯HHSãCOVID-19ã¯ã¯ãã³å·å®³ããŒãã«ãäœæãããšçºè¡šããŸãããããã«ãããCOVID-19ã¯ã¯ãã³ã§è² å·ãã人ã ãå¥ã®é£éŠããã°ã©ã ã§ããã«ãŠã³ã¿ãŒã¡ãžã£ãŒå·å®³è£åããã°ã©ã ããè£åãåãããããªãå¯èœæ§ããããŸãã
ãã€ã¿ãŒã«ãããšãã±ããã£ã¯ãã©ã³ãã®æ¯æãåŸãŠããããã§ããæ°ãæããšã«ãçŽè¿ã§ã¯6æã«ãã¯ã¯ãã³é¢é£ã®åãçµã¿ã«ã€ããŠè©±ãåã£ãŠããŸãã
ãã®æ¯æã瀺ããããã©ã³ã倧統é ã¯5æã«å€§çµ±é 什ã«çœ²åããå ¬è¡è¡çæ©é¢ã«å¯Ÿããç±³åœã®å ç«¥äºé²æ¥çš®ã¹ã±ãžã¥ãŒã«ããåçã®å é²åœã®ç§åŠç蚌æ ãšãã¹ããã©ã¯ãã£ã¹ããšæŽåãããããæç€ºããŸããã